(AOF) – The Lumibird group, a specialist in laser technologies, has finalized the agreement with the Italian company Prima Industrie for the acquisition of its subsidiary Convergent Photonics and the assets of Convergent held by Prima Industrie North America (Boston, USA) . This acquisition provides Lumibird with innovative solutions and autonomy in semiconductors and high-power fiber lasers while opening up new markets.
This acquisition presents “a double strategic interest” for Lumibird, on the one hand by strengthening its autonomy in semiconductors and very high power fiber lasers, and on the other hand, by opening up new market segments.
It also complements with the arrival of the semiconductor, the strategic investments already made in optical fiber and derived components.
It allows Lumibird to become independent in the long term on the supply of critical components and gives it increased innovation capabilities at the level of materials and components, while internalizing the margins of expensive components.
Lumibird, which will also publish its half-year results on September 26, financed its acquisition by drawing down the bank lines available to the group, in compliance with the covenants.
AOF – LEARN MORE
Find out more about the Pharmacy sector
Biotechs put to the test
These companies are suffering from a much less favorable economic cycle, which is reflected in particular by a drop in financing by venture capital for start-ups. These companies are therefore obliged to carry out redundancy plans. Added to this is a much more restrictive regulatory framework. First, in the United States, the measures linked to the Inflation Reduction Act (IRA) could have a strong impact on the margins of the participants. Indeed, from 2026, the federal Medicare program will be able to renegotiate the price of drugs marketed for nine years (chemicals) or 13 years (biologicals), with discounts that could range from 35 to 60% for biotechs. Similarly, in Europe, with the new drug regulations presented in Brussels in April, the duration of patent protection will be reduced if the innovative treatment is not marketed in all member countries within two years.
Learn more about the Capital Goods sector
Rail investment plan
The French railway industry ranks second in Europe and third worldwide. This industry has a trade surplus, which generates more than 100,000 jobs in France. The announcement of the future plan for French rail transport provides in particular for the regeneration and modernization of the network, the average age of which is 30 years in our territory. This age is much higher than in countries like Germany (17) and Switzerland (15). An annual investment rising from 2.8 billion euros to nearly 4 billion euros should enable the entire network to be maintained in good condition.